摘要
小细胞肺癌(Small Cell Lung Cancer, SCLC)作为一种肝癌亚型,其恶性程度高,转移早,患者预后差,对社会及患者家庭造成严重医疗负担。本文以小细胞肺癌肝转移生物基础及分子机制为视角,对小细胞肺癌肝转移的机制和预测指标的最新研究进展进行综述。与此同时,对当前关于预测SCLC肝转移的生物标志物的研究进行评估并简要概述当前治疗策略,最后对SCLC未来研究方向进行展望,目的在于为临床治疗和未来研究提供参考。
Small cell lung cancer (SCLC), as a subtype of liver cancer, has high malignant degree, early metastasis and poor prognosis, which causes serious medical burden to the society and patients’ families. From the perspective of biological basis and molecular mechanism of liver metastasis of small cell lung cancer, this paper reviews the latest research progress on the mechanism and predictive indexes of liver metastasis of small cell lung cancer. At the same time, the current research on biomarkers predicting SCLC liver metastasis was evaluated and the current treatment strategies were briefly summarized. Finally, the future research direction of SCLC was prospected, in order to provide reference for clinical treatment and future research.
出处
《临床个性化医学》
2024年第2期180-186,共7页
Journal of Clinical Personalized Medicine
